Patent: 10,655,156
✉ Email this page to a colleague
Summary for Patent: 10,655,156
| Title: | Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins |
| Abstract: | Methods of modulating the properties of a cell culture expressing a protein of interest are provided. In various embodiments the methods relate to the overexpression of proteins involved in the N-glycosylation pathway. |
| Inventor(s): | Shivani Gupta, Sohye Kang |
| Assignee: | Amgen Inc |
| Application Number: | US16/261,311 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,655,156
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | PROLIA | denosumab | Injection | 125320 | 1-Jun-10 | ⤷ Start Trial | 2039-01-29 |
| Amgen Inc. | XGEVA | denosumab | Injection | 125320 | 18-Nov-10 | ⤷ Start Trial | 2039-01-29 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,655,156
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2015116315 | ⤷ Start Trial |
| United States of America | 10106829 | ⤷ Start Trial |
| United States of America | 10227627 | ⤷ Start Trial |
| United States of America | 10907186 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
